NervGen Pharma Corp. (TSXV: NGEN) (OTCQB: NGENF), a clinical-stage biotech company dedicated to developing innovative ...
SciSparc submits IND application to US FDA for phase IIb trial for Tourette syndrome: Tel Aviv, Israel Friday, September 20, 2024, 17:30 Hrs [IST] SciSparc Ltd., a specialty clini ...
Barclays analyst Gaurav Jain said in a report released Sept. 13 that the industry is benefiting from four recent FDA ...
As the industry fights a ban on menthol cigarettes, a Reynolds American subsidiary has become the largest corporate donor to the main pro-Trump super PAC.
The U.S. Food and Drug Administration's (FDA) warning letter to Agena Bioscience, issued on March 21, 2024, marks a significant shift in enforcement priorities, targeting the improper labeling of ...
Pro and college athletes are wearing the Q-Collar to reduce their risk of brain injuries, but data sleuths have spotted anomalies and errors in key studies demonstrating its efficacy.
The majority of FDA-recalled devices made it to market via the 510(k) pathway, which doesn’t require new clinical or safety ...
Checkpoint Therapeutics, Inc. (CKPT), a clinical-stage immunotherapy and targeted oncology company, announced Monday longer-term data ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback